期刊
CANCER NANOTECHNOLOGY
卷 8, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12645-017-0027-z
关键词
Cancer diagnosis; Imaging contrast agents; External beam radiotherapy; Stereotactic ablative radiotherapy; Radiosensitisation; Theranostic nanoparticles; Prostate cancer
资金
- Prostate Cancer UK
- Movember foundation [CEO13_2-004]
- R&D division of the Public Health Agency [COM/4965/14]
- Prostate Cancer UK [CEO13_2-004] Funding Source: researchfish
- Public Health Agency [COM/4965/14, SPI/3315/06] Funding Source: researchfish
Over the past two decades, there has been a significant evolution in the technologies and techniques employed within the radiation oncology environment. Over the same period, extensive research into the use of nanotechnology in medicine has highlighted a range of potential benefits to its incorporation into clinical radiation oncology. This short communication describes key tools and techniques that have recently been introduced into specific stages of a patient's radiotherapy pathway, including diagnosis, external beam treatment and subsequent follow-up. At each pathway stage, consideration is given towards how nanotechnology may be combined with clinical developments to further enhance their benefit, with some potential opportunities for future research also highlighted. Prospective challenges that may influence the introduction of nanotechnology into clinical radiotherapy are also discussed, indicating the need for close collaboration between academic and clinical staff to realise the full clinical benefit of this exciting technology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据